PacBio News and Activities
Presence
PacBio develops genetic analysis tools and sequencing systems. Its products and services support research laboratories, healthcare organizations, and biotechnology companies that study DNA, RNA, and related biological samples.
PacBio products and services overview:
- DNA sequencing
- Genetic analysis tools
- Research instruments
- Consumable kits
- Software solutions
- Laboratory services
Revenue: ~$154 million
Employees: 1,200
Headquarters: Menlo Park, United States (USA)
Illumina is one of the...
Illumina is a company listed under the stock ticker ILMN (US).
Illumina has 4 subsidiaries including Grail, Illumina Ventures and PacBio.
They are in:
- Biotechnology60%
- Medical Equipment20%
- Other20%
Acquisition, funding and merger involving Illumina.
- Illumina has acquired SomaLogic (posted on January 30 2026).
- Illumina has announced the acquisition of SomaLogic (posted on June 23 2025).
Executives
View the org chart displaying its 21 main executives
Most searched biographies at PacBio
- Christian Henry, Chief Executive Officer and Interim Chief Financi...
- Bill Ericson, Director
- Marshall Mohr, Director
Popular executive movements at PacBio
- Chris Smith, Director, has left the company (posted on July 10 2026).
- Diane Yearwood, who was Director, Corporate, Securities & Stock Administration, is promoted to Senior Director, Corporate Legal and Stock Administration (posted on March 6 2026).
- David Ruggiero, Head, Global Sales and Service, has left the company (posted on March 6 2026).
Click here to view some more movements at PacBio
Popular executive movements at Illumina
- Mike Sullivan will join the company as Chief Commercial Officer on Jul. 20, 2026 (posted on July 10 2026).
- Julie Coletti will join the company as Chief Legal Officer on Aug. 3, 2026 (posted on July 10 2026).
- Daniel Skovronsky has joined the company as Director (posted on June 24 2026).
Click here to view some more movements at Illumina
Create your alert
to follow the executive moves at PacBio.
Biotechnology
Illumina has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).
Popular M&A news in Biotechnology
- The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
- Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
- Tissium has just announced a $60 Million fundraising (posted on July 8 2026).
Popular contacts in Biotechnology
News
Press releases by PacBio
- PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing - PacBio
- PacBio to Participate in the Jefferies Global Healthcare Conference - PacBio
- PacBio Announces First Quarter 2026 Financial Results - PacBio
- HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss - PacBio
- PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing - PacBio
- PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 - PacBio
- PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples - PacBio
- Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative - PacBio
- PacBio Announces the Appointment of Chris Gibson to the Board of Directors - PacBio
- PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research - PacBio
- View more press releases Close
Social media about PacBio
- PacBio on Wikipedia, Google News & Yahoo Finance
- PacBio on LinkedIn, X (Twitter) & YouTube
